Human 5-HT 7A receptors positively modulated adenylyl cyclases via G s subtypes of G proteins in human embryonic kidney 293 cells, and bound 5-hydroxytryptamine (HT) with high and low affinity (K I values of 1.5 Ϯ 0.3 and 93 Ϯ 4 nM). More than 60% of 5-HT 7A receptors, however, displayed the high-affinity 5-HT binding with no sensitivity to 5Ј-guanylylimidodiphosphate. In this study, we found that select amphipathic agents affected the high-affinity 5-HT binding to 5-HT 7A
5-HT
Receptors are G protein-coupled receptors with seven transmembrane segments, (Bard et al., 1993; Ruat et al., 1993; Shen et al., 1993) , and exist in three alternatively spliced isoforms (Heidmann et al., 1997; Jasper et al., 1997; Stam et al., 1997; Heidmann et al., 1998) . The predominant isoform, 5-HT 7A , is localized in discrete limbic regions (thalamus and hypothalamus) of the brain as well as peripheral tissues, including coronary artery and certain gastrointestinal tissues (Meyerhof et al., 1993; To et al., 1995; Leung et al., 1996) . Multiple physiological roles have been proposed for the receptor, such as regulation of circadian rhythms [because of its presence in the suprachiasmatic nucleus of the hypothalamus (Lovenberg et al., 1993; Kawahara et al., 1994) ], mood and emotions [because of its limbic location and its high-affinity interactions with antipsychotics and antidepressants (Adham et al., 1998; Meyerhof et al., 1993; To et al., 1995) ], and also migraine genesis [because of its smooth muscle relaxing activity (Leung et al., 1996; Cushing et al., 1996) ]. At cellular level, the 5-HT 7A receptor, when expressed heterologously in mammalian cells, positively modulates adenylyl cyclases (Bard et al., 1993; Ruat et al., 1993; Shen et al., 1993; Adham et al., 1998) via activation of G s subtypes of G proteins. We confirmed here that the human 5-HT 7A receptor as expressed heterologously in human embryonic kidney (HEK) 293 cells mediates the cholera toxin-sensitive cAMP production. At the same time, we observed that most receptors (Ͼ 60%) bound 5-HT with high affinity. Classically, high-affinity agonist binding represents the phenotype for G protein-bound receptors, but was unusual for 5-HT 7A in its marked abundance and insensitivity to 5Ј-guanylylimidodiphosphate (GppNHp), as observed here. In this study, we explored whether phospholipid metabolites and similar amphipathic compounds could modulate the 5-HT 7A receptor, a membrane-embedded receptor. Such possibilities were hinted at by earlier reports that oleamide and oleic acid influenced 5-HT 7A receptors expressed in HeLa cells (Hedlund et al., 1999) . In addition, our preliminary experiments showed that fatty acid-free bovine serum albumin (FF-BSA), a scavenger of lipid metabolites, markedly affected binding of 
Materials and Methods
The cDNA for the human 5-HT 7A receptor has been cloned into a PCI-Neo mammalian expression vector. The vector was used for transfection of HEK293 cells, using Ca 2ϩ phosphate precipitation techniques. Cells were selected for a month in the presence of G-418 (400 g/ml). Transcripts for 5-HT 7A were robustly detected with reverse transcription-polymerase chain reaction (using 3Ј rapid amplification of cDNA ends reaction) from transfected but not naive cells. Cell membranes were prepared by standard procedures including homogenization and differential centrifugation as described elsewhere (Pregenzer et al., 1993) . Binding of radioactive ligands was measured in membranes expressing recombinant receptors, using filtration techniques as described elsewhere (Pregenzer et al., 1993 (Chabert et al., 1994; Pregenzer et al., 1997) , in the medium containing 25 mM HEPES, pH 8.0, 100 mM NaCl, 1 mM EDTA, 3 mM MgCl 2 , 0.5 mM dithiothreitol, 0.003% digitonin, 2 nM GTP␥ 35 S (5 to 3 ϫ 10 5 cpm/assay), and 10 g of membrane protein in a volume of 200 l. Digitonin was used at trace amounts here, solely to make the membranes permeable to GTP␥ 35 S. Test ligands were included at 10 M, unless indicated otherwise. Membranes were preincubated with 100 M 5Ј-adenylylimidodiphosphate for 30 min, 10 M GDP for 10 min on ice, and then were added to the rest of reaction components. In some experiments, membranes were treated with N-ethylmaleimide (NEM) at 100 M, and excess NEM was neutralized with ␤-mercaptoethanol at the end of 30-min incubation. Reaction mixtures were incubated at 30°for 30 min and were filtered over Whatman GF/B filters under vacuum. Filters were washed three times with 4 ml of ice-cold buffer containing 100 mM NaCl, 20 mM Tris/HCl, pH 8.0, and 25 mM MgCl 2 . Agonist-induced GTP␥ 35 S binding was obtained by subtracting that observed without agonists. The binding data were analyzed using nonlinear regression method (Sigma Plot), and presented with mean values Ϯ S.E. Cellular changes in cAMP were measured using a FlashPlate assay kit from PerkinElmer Life Science Products (Boston, MA). Briefly, cells were grown in a 96-well plate to about 80%confluence, washed three times with phosphate-buffered saline, and treated with test ligands for 30 min. cAMP in cell lysates were measured using the competition between 125 I-cAMP and nonradioactive antigen for a fixed number of antibody binding sites in microplates coated with solid scintillant. GTP␥ 35 S-bound G␣ subunits were identified following the method described elsewhere (Okamoto et al., 1992 ) with a modification (Alberts, et al., 1999) : the activation of receptors with serotonin in the presence of GTP␥ 35 S before membrane solubilization with detergents. Briefly, membranes were incubated in the presence of GTP␥ 35 S (4 nM) and serotonin (10 M) under conditions identical to those for GTP␥ 35 S binding as described above. Treated membranes were solubilized with an equal volume of a buffer containing 100 mM Tris/HCl, pH 8.0, 10 mM MgCl 2 , 100 mM NaCl and 0.6% CHAPS for 30 min on ice, and were diluted to a final CHAPS concentration of 0.125%. An aliquot of the mixtures (typically 300 l) was transferred to a well in a 96-well plate that had been coated successively with goat anti-rabbit antibodies (1:100 dilution), bovine serum albumin (5 mg/ml), and one of the affinity-purified rabbit antibodies for various G␣ subunits (1:200 dilution). After incubation for 1 h at room temperature and washing, each well was counted for 35 S using a standard scintillation cocktail and a ␤-counter. The antibodies we used here include those specific for G␣ i (the C-terminal sequence, 345-354), G␣ s (the C-terminal sequence, 385-394), G␣ q/11 (the common C-terminal sequence, QLNLKEYNLV), or G␣ 13 (the sequence 367-377) from Calbiochem (San Diego, CA). The mouse monoclonal anti- body raised against bovine G o protein was obtained from Chemicon (Temecula, CA). Agonist-induced GTP␥ 35 S binding was computed by subtracting the level observed without test agonists. Stock solutions were prepared in 0.1% ascorbic acid for monoamines, in dimethyl sulfoxide for lysophospholipids, and in alcohol for fatty acids and oleamide. Dilutions were made in borosilicate glass tubes, and final concentrations of dimethyl sulfoxide or alcohol were less than 0.5%. CHAPS and FF-BSA were prepared in the assay buffer. Reactions were carried out in polypropylene microtubes.
Results

Binding of [
3 H]5-HT and [ 3 H]mesulergine (antagonist) to the human 5-HT 7A receptor, when expressed heterologously in HEK293 cells, fitted well to a one-site binding model (linearity) with dissociation constants (K D ) of 1.5 Ϯ 0.1 and 4.3 Ϯ 0.1 nM, respectively, and maximal binding values of 1.7 Ϯ 0.2 ( Fig. 1 ) and 2.6 Ϯ 0.1 pmol/mg of protein, respectively ( Fig. 1 (Fig. 1) .
We also examined agonist-induced GTP␥ 35 S binding to G␣ subunits. At 5-HT 7A , 10 M 5-HT-induced GTP␥ 35 S binding increased as a function of GTP␥ 35 S concentrations (0.5 to 20 nM), with an EC 50 value of 2.2 Ϯ 0.8 nM and maximal binding of 270 Ϯ 32 fmol/mg of protein (Fig. 2) . Similar values were observed with dopamine-activated D1 dopamine receptors (2.6 Ϯ 0.3 nM and 330 Ϯ 53 fmol/mg of protein) (Fig. 2) . Methiothepin (100 M) by itself produced no effect on the basal level, but blocked 1 M 5-HT-induced GTP␥ 35 S binding at 5-HT 7A (24 Ϯ 4% over the basal) whereas 100 M SCH23390 blocked dopamine-induced GTP␥ 35 S binding at D1 (Fig. 2) . Moreover, at 5-HT 7A , the methiothepin-sensitive GTP␥ 35 S binding was primarily associated with G␣ s , as detected with the immobilization method with various G␣-specific antibodies (Okamoto et al., 1992) . The relative levels of GTP␥ 35 S association with the antibodies specific for G␣ s , G␣ i , G␣ o , G␣ q , and G␣ 13 were 24 Ϯ 3, 5 Ϯ 2, 1 Ϯ 1, 4 Ϯ 4, and 0 Ϯ 1%, respectively, above the basal binding (no 5-HT in anti-G␣ s -coated wells) (Fig. 2) .
Generally, G i /G o subtypes are the most abundant and active cellular G proteins contributing to GTP␥ 35 S binding. To evaluate independently the potential involvements of G i /G o subtypes at 5-HT 7A , membranes were treated with 100 M NEM, an established, selective inhibitor of G i /G o subtypes (Winslow et al., 1987; Nakajima et al., 1990; Alberts et al., 1999) . NEM treatment decreased the basal GTP␥ 35 S (2 nM) binding by 21 Ϯ 3, but with no appreciable effect on the net 5-HT-induced GTP␥ 35 S binding (Fig. 2) . This further supports the primary association of 5-HT 7A with G s but not G i /G o subtypes.
We examined the effects of lipid metabolites and similar amphipathic compounds on the 5-HT 7A receptor, because such agents have been reported to allosterically modulate various membrane receptors (Koenig and Martin, 1992; Hedlund et al., 1999 (Fig. 3) . At 3%, FF-BSA decreased [
3 H]5-HT (2 nM) binding by 46 Ϯ 4%. Scatchard analysis showed a decrease in maximal 5-HT binding from 1.7 Ϯ 0.2 to 1.1 Ϯ 0.1 pmol/mg of protein, with no appreciable 3 H]mesulergine were carried out with several serotonergic ligands at various concentrations in HEK293 cell membranes expressing 5-HT 7A receptors. Only displacement data for 5-HT and 5-CT were fitted to a two-site binding model; the rest were fitted to a one-site binding model. The values in parentheses represent the relative fraction of high-and low-affinity sites. The IC 50 values from dose-response profiles were converted to K I (Cheng and Prusoff, 1973) . Intrinsic efficacy for ligands was estimated from an increase in cellular cAMP in intact cells or in 2 nM GTP␥ 35 S binding in isolated membranes and normalized for that obtained with 10 M serotonin. The data represent mean Ϯ S.E.M. (n ϭ 3). (Fig. 4) (Fig.  3 ). These differences in receptor sensitivity could be ascribed to various factors, including species variations in rat and human receptors and possibly different surrounding lipid environments in the HeLa and HEK293 cells. In fact, the rat 5-HT 7A in HeLA cells displayed a K D value for 5-HT (12.68 nM) nearly 10-fold greater than the human counterpart in HEK293 cells (1.5 nM) (Hedlund et al., 1999) .
Compounds
We also studied lysophospholipids, which are also generated from hydrolysis of phospholipids by phospholipases. (Fig. 3) . In the presence of 0.1% CHAPS, maximal [
3 H]5-HT binding increased from 1.7 Ϯ 0.2 to 2.6 Ϯ 0.1 pmol/mg of protein, with no appreciable change in its K D value (1.4 Ϯ 0.1 nM compared with 1.5 Ϯ 0.1 nM). For [ 3 H]mesulergine binding, 0.1% CHAPS showed no effect on maximal binding (2.5 Ϯ 0.2 compared with 2.6 Ϯ 0.1 pmol/mg of protein) but increased its K D value from 4.3 Ϯ 0.1 to 6.9 Ϯ 0.4 nM. The opposite effects by lysophaphatidyl choline and CHAPS, two similar zwitterions, suggest that their actions arise from specific interac- S at 2 nM for 30 min, and then solubilized with CHAPS at 0.3%. Solubilized G␣ subunits were immobilzed with various G␣-specific antibodies. The data presented as percent increase from the basal value observed without agonist treatment, and are the mean Ϯ S.E.M (n ϭ 3).
tions with receptors, not from general membrane perturbations.
Functionally, these agents also affected 5-HT-induced GTP␥ 35 S binding. FF-BSA (3%) and 50 M lysophosphatidyl choline reduced 10 M 5-HT-induced GTP␥ 35 S binding to 56 Ϯ 4 and 55 Ϯ 10%, respectively, as normalized to that observed with 10 M 5-HT, whereas oleic acid and CHAPS increased the GTP␥ 35 S binding to 137 Ϯ 5 and 133 Ϯ 7%, respectively. In the analogous Gs-coupled D1 receptor, however, 15 M oleic acid, 3% FF-BSA, 50 M lysophosphatidyl choline, and 0.1% CHAPS produced no appreciable effects on 10 M dopamine-induced, SCH-23390-sensitive GTP␥ 35 S binding (96 Ϯ 28, 95 Ϯ 3, 83 Ϯ 16, and 109 Ϯ 22%, respectively). Cellular cAMP changes were monitored using a FlashPlate assay kit from PerkinElmer in HEK 293 cells in a 96-well plate. A standard curve with various concentrations of cAMP was constructed, following the vendor's protocol. The basal levels of cAMP were less than 0.2 pmol/well and were not appreciably affected by addition of the listed compounds. The 5-HT-induced GTP␥ 35 S binding was measured in isolated HEK 293 cell membranes in the presence or absence of 10 M 5-HT and 2 nM GTP␥ 35 S. Methiothepin at 100 M blocked 5-HT-induced GTP␥ 35 S binding and by itself showed no effect. The data represent the mean Ϯ S.E.M. (n ϭ 3). 
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We also examined how these agents affect cAMP accumulation at 5-HT 7A in the HEK293 cell. Typically, 5-HT increased cAMP production in a concentration-dependent manner with an EC 50 value of 8.1 Ϯ 0.7 nM and maximal stimulation of 9 Ϯ 1 pmol/well in a 96-well plate (Fig. 4) . With cholera toxin treatment (5 g/ml culture for overnight), the basal level of cAMP increased from 0.1 to 4 pmol/well, but 5-HT produced no responses; the covalent modification of G s subtypes by cholera toxin (ADP-ribosylation) rendered them into permanently activated states (Milligan, 1988) . FF-BSA at 3% and lysophosphatidyl choline at 50 M showed no effects on the basal cAMP production (Ͻ0.2 pmol/well) but increased the 5-HT concentration (EC 50 ) from 8.1 to 13.9 Ϯ 1.2 and 15.8 Ϯ 1.6 nM, respectively, without affecting maximal cAMP production (9.1 Ϯ 0.8 and 8.3 Ϯ 0.3 pmol/well, respectively; Fig. 4 and Table 2 ). On the other hand, 15 M oleic acid and 0.1% CHAPS decreased the EC 50 value from 8.1 Ϯ 0.7 to 3.7 Ϯ 0.4 and 4 Ϯ 1 nM, respectively, but with little effect on maximal production (8.4 Ϯ 0.3 and 9 Ϯ1 pmol/well, respectively) and on basal cAMP production.
Discussion
The human 5-HT 7A receptor is a G s -coupled receptor; when expressed heterologously in HEK293 cells, more than 60% of its population displayed high-affinity [ 3 H]5-HT binding. We discovered here that the high-affinity agonist binding decreased in the presence of FF-BSA and increased in the presence of oleic acid without appreciable effects on antagonist binding. The actions of FF-BSA and oleic acid seem to be highly selective for 5-HT 7A , judging from the following observations. 1) FF-BSA and oleic acid showed no appreciable effects on [ 3 H]5-HT binding to analogous 5-HT receptors (5-HT 1D and 5-HT 2C ). 2) Structural analogs of oleic acid, such as palmitic, stearic, and arachidonic acids, were not effective. 3) FF-BSA lost its action when preincubated with inactive 10 M stearic acid, supporting its role in scavenging endogenous lipid metabolites rather than protein-protein interaction. 4) FF-BSA and oleic acid reduced maximal binding for 5-HT, not the K D value, indicating their selective action at receptors. 5) Oleic acid was effective at concentrations (Ͻ15 M) too low to form micellar structures, and its action was not mimicked by lysophospholipids, another class of amphipathic lipid metabolites. 6) In general, the human 5-HT 7A receptor seems to be susceptible to allosteric modulations by amphipathic agents. For example, lysophosphatidyl choline decreased maximal 5-HT binding for 5-HT (not antagonist binding), and CHAPS, a similar zwitterion, increased it. From these results, we propose that endogenous amphipathic compounds, probably including oleic acid and others that remain unidentified, may allosterically modulate 5-HT 7A to increase high-affinity 5-HT binding.
In addition, the amphipathic compounds at concentrations that selectively affected In this study, we also observed that GppNHp produced no appreciable effect on the high-affinity agonist binding to 5-HT 7A but abolished high-affinity dopamine binding to D1. Two possibilities can be cited: 1) At 5-HT 7A , a certain portion could be sensitive to GppNHp but not detectable because the overwhelming majority of high-affinity binding was insensitive to the guanine nucleotide. 2) 5-HT 7A receptors could form a very tight complex with Gs that could not be destabilized by GppNHp. A similar situation has been proposed for Table 2 for parameters). B, 5-HT-induced cAMP production was measured in intact cells using 
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Mel 1a -metatonin receptor and G i (Roka et al., 1999) . Further study will be needed.
In summary, endogenous amphipathic lipid metabolites that could be scavenged by FF-BSA, such as oleic acid, seem to allosterically modulate 5-HT 7A to enhance its high-affinity agonist binding, at least in part, and to confer more efficient coupling with G s subtypes of G proteins. Their interactions with 5-HT 7A seem to be specific, judging from the narrow structural requirement for modulators (oleic acid and CHAPS) and their inactivity at analogous 5-HT and dopamine receptors.
